|
2022 |
Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2015 |
Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2015 |
Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury. |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2015 |
Temperature differentially facilitates spontaneous but not evoked glutamate release from cranial visceral primary afferents. |
Tally Largent-Milnes, PhD |
|
2012 |
Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism. |
Nam Lee, Ph.D. |
|
2004 |
The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. |
|
|
2004 |
The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells. |
|
|
2016 |
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain. |
Tally Largent-Milnes, PhD, Patrick W Mantyh, Todd Vanderah, PhD |
|
2012 |
The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. |
|
|
2023 |
The Drinking Water and Swimming Pool Disinfectant Trichloroisocyanuric Acid Causes Chlorination Stress Enhancing Solar UV-Induced Inflammatory Gene Expression in AP-1 Transgenic SKH-1 Luciferase Reporter Mouse Skin. |
Sally Dickinson, Ph.D. |
|
2011 |
The effect of dietary soy isoflavones before and after ovariectomy on hippocampal protein markers of mitochondrial bioenergetics and antioxidant activity in female monkeys. |
Roberta Diaz Brinton, Ph.D |
|
2021 |
The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area. |
Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2020 |
The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2021 |
The FDA Mandate to Reassess Benzodiazepines: Alprazolam Induces a Positive Conditioned Place-Preference if Male Rate |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2014 |
The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth. |
|
|
2008 |
The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. |
Roberta Diaz Brinton, Ph.D |
|
2012 |
The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration. |
|
|
2015 |
The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. |
John M. Streicher, PhD |
|
2023 |
The natural product argentatin C attenuates postoperative pain via inhibition of voltage-gated sodium and T-type voltage-gated calcium channels. |
John M. Streicher, PhD |
|
2015 |
The perimenopausal aging transition in the female rat brain: decline in bioenergetic systems and synaptic plasticity. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2008 |
The role of COX-2 in heart pathology. |
John M. Streicher, PhD |
|
2011 |
The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Therapeutic potential of peroxynitrite decomposition catalysts: a patent review. |
Todd Vanderah, PhD |
